Merck Serono and Medicines for Malaria Venture sign agreement to develop potential antimalarial therapy
2 April 2015 | By Victoria White
Merck Serono and MMV have announced that an agreement has been signed for Merck Serono to obtain the rights to the antimalarial compound DDD107498...